rizwan a. manji md phd frcsc mba - umanitoba.ca · rizwan a. manji md phd frcsc mba 2 • cae...

Rizwan A. Manji MD PhD FRCSC MBA

Curriculum Vitae

Current Position

Cardiac Surgeon/Intensivist

Cardiac Sciences Program

CR3014 – 369 Tache Avenue

Winnipeg, Manitoba, R2H 2A6

Phone: (204) 258-1031

Fax: (204) 231-4624

E-mail: [email protected]

2007 – present: Assistant Professor, Department of Surgery

2012 – present: Assistant Professor, Department of Anesthesia

University of Manitoba

Degrees and Licenses

M.B.A. Masters of Business Administration, University of Manitoba I.H. Asper School of Business,

Winnipeg, Manitoba, Canada – February 2008

F.R.C.P.C. Fellow of the Royal College of Physicians of Canada in Critical Care Medicine, Ottawa,

Ontario, Canada – September 2007

F.R.C.S.C Fellow of the Royal College of Surgeons of Canada in Cardiac Surgery, Ottawa, Ontario,

Canada – June 2005

Ph.D. Doctor of Philosophy in Experimental Surgery, University of Alberta, Edmonton, Alberta,

Canada – November 2001

Licentiate Medical Council of Canada – 1997

M.D. Doctor of Medicine with Distinction and Honours in Research, University of Alberta,

Edmonton, Alberta, Canada – June 1995

B.M.Sc. Bachelor of Medical Science with Distinction, University of Alberta, Edmonton, Alberta,

Canada – November 1993

Other education

• CALS (Cardiac Surgery Advanced Life Support) training course

• TEE training - SCA Atlanta, Georgia

April 25, 2015

May 5-11, 2013

mailto:[email protected]


2

• CAE Ultrasound Course – Online Training 2012

• Completion of United States Medical Licensing exam (USMLE) parts

1 and 2

1996

• Advanced Cardiac Life Support, Pediatric Advanced Life Support,

and Advanced Trauma Life Support, Grant MacEwen Community

College and Royal Alexandra Hospital, Edmonton, Alberta,

Canada-

1995

• General Sciences (specialization in Cell Biology), University of

Alberta, Edmonton, Alberta, Canada

1989-1991

Academic Awards

• Archer Daniels Midland Fellowship, I.H. Asper School of Business,


Sept. 2006

• First Place Critical Care Medicine In-training exam, University of

Manitoba

Dec. 2005

• Cardiac Surgery First Prize – 97th percentile rank in Cardiac Surgery

in American Association of Thoracic Surgery Exam, University of

Alberta

2005

• Cardiac Surgery First Prize – 93rd

percentile rank in Cardiac Surgery

in the American Association of Thoracic Surgery Exam, University

of Alberta

2004

• Cardiac Surgery First Prize – 96th percentile rank in Cardiac Surgery

in the American Association of Thoracic Surgery Exam, University

of Alberta

2003

• Mosby Book Award – Excellent Academic Standing in Medical

School Class, University of Alberta

1995

• First Prize in Dermatology, University of Alberta 1995

• Aga Khan Foundation Canada Scholarship for Academic Excellence,

University of Alberta

1991-1994

• Nat Christie Foundation Scholarship for Academic Excellence 1993

• Dr. Allan Coates Rankin Prize in Medical Microbiology and

Infectious Diseases

1993

• Louise McKinney Post-Secondary Scholarship, University of Alberta 1992

• Prime Evils Athletic Association Scholarship 1990


3

CLINCIAL

Clinical Work Experience

• Intensivist – Winnipeg Regional Health Authority – Cardiac Surgery

and General Systems

• House Medical Officer – Critical Care Medicine, Grace and

Concordia Hospitals, Winnipeg, Manitoba

2007 - present

2005-2007

• Advanced Cardiac Life Support Medical Director and Instructor –

Grant MacEwan Community College, Edmonton, Alberta

1999-2005

• Advanced Trauma Life Support instructor – Royal Alexandra

Hospital, Edmonton, Alberta

1998-2005

• Basic Trauma Life Support Medical Director and Instructor – Grant

MacEwan Community College, Edmonton, Alberta

1998-2005

RESEARCH

Research Experience

• Outcome Studies in Patients on Extracorporeal Life Support Jun. 2012 - Present

• Rheumatic Heart Disease in Ethiopia – Prevalence Study and Cost-

Effectiveness Study for Prevention of Rheumatic Heart Disease –

Collaborative study with Dr. Julia Witt (Department of Health

Economics, University of Manitoba) and Dr. Richard Northcott

(Canadian Humanitarian Organization for International Relief)

Feb. 2012 - Present

• Gal Knockout Transgenic Pig Valves for Bioprothetic Heart Valve

Replacement – Collaborative study with Dr. Cooper (University of

Pittsburg), Dr. Mohiuddin (National Institutes of Health) and Dr.

David Ayares (Revivicor)

Dec. 2011 - Present

• Outcome Studies in Cardiac Surgery and Cardiac Surgery Critical

Care, University of Manitoba, Winnipeg, Manitoba

Oct. 2007 - Present

• Cardiac Responsiveness to Dobutamine as Predictor of Outcome from

Septic Shock in ICU Patients, University of Manitoba, Winnipeg,

Manitoba

Sept. 2006

• Tolerance Studies in Xenotransplantation in Infants – Collaborative

Study with Dr. David Cooper – Thomas Starzl Transplantation

Institute, University of Pittsburgh Medical Centre, Pittsburgh, PA,

USA

2005 – 2007


4

• Xenoantibodies and Bioprosthetic Cardiac Valve Failure, University

of Alberta, Edmonton, Alberta

2003 - 2007

• Human ABO Blood Group and Anti-a-Gal Antibody Depletion in a

Porcine Human Working Heart Xenotransplantation Model of

Hyperacute Rejection – Ph.D. thesis – University of Alberta,

Edmonton, Alberta

1998 – Nov. 2001

Research Awards

• Citation Finalist - Society of Critical Care Medicine annual meeting

2011 – Abstract: What is the Usefulness of 4T Test and Enzyme

Linked Immunosorbent Assay in Decision Making in Post Cardiac

Surgical ICU Patients Suspected of Heparin Induced

Thrombocytopenia?

Jan 15-19, 2011

• Postgraduate Medical Publication Research Prize – Manuscript:

Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify

and Fail from Xenograft Rejection, University of Alberta

May 2005

• NewEra Cardiac Care Scholarship to attend and present at Innovation

& Technology meeting

Jan. 2005

• George Graham Bursary for Excellence in Resident Research,


Oct. 2002

• University of Alberta Medical Staff Society Resident Publication

Prize – Manuscript: Human ABO Blood Group is Important in

Survival and Function of Porcine Working Hearts

June 2002

• CIHR Resident Publication Prize – Manuscript Human ABO Blood

Group if Important in Survival and Function of Porcine Working

Hearts, University of Alberta

May 2002

• Finalist in Student Award Competition Canadian Cardiovascular

Congress Meeting, Halifax, Nova Scotia, for abstract: Critical

Factors in Survival of a Pig-Human Xenograft

Oct. 2001

• Nominated for NSERC Doctoral Research Award, Department of

Surgery, University of Alberta

Sept. 2001

• Best Abstract Award (Student - Transplantation) – 6th Symposium of

World Artificial Organ, Immunology, and Transplantation Society,

Ottawa, Ontario

Aug. 2001

• Winner General Surgery Resident Research Day abstract: Testing the

Efficacy of Specific Anti-a-Gal Antibody Depletion at Prolonging

Survival of an Ex-vivo Porcine Working Heart in Porcine-Human

Apr. 2000


5

Cardiac Xenotransplantation

• Winner Student Research Day (oral presentation), Faculty of

Medicine, University of Alberta

1992

Grants

• Department of Surgery Research Grant ($14997) – The ETHICS

Study – Ensuring patients THrive after prolonged Intensive care

unit stay following Cardiac Surgery – A Pilot Study – Co-

Investigator

• Department of Surgery Research Grant ($8400) – Xenograft Rejection

of Commercially Used Bioprosthetic Heart Valves – Principal

Investigator

• Department of Surgery Research Grant ($14,875) - The Prolonged

Stay Cardiac Surgery ICU Patient: Characterization and Long Term

Outcomes – Principal Investigator

• Anesthesia Oversight Committee Research Awards ($10,000) for

studies in Heparin Induced Thrombocytopenia

Jan 2015 - present

Jan 2015 - present

2013-present

2010

• Manitoba Medical Services Foundation Operating Grant ($35,000) for

work entitled: Stains and Bioprosthetic Heart Valve

Inflammation/Calcification – joint grant with Dr. R. Arora and Dr.

D. Jassal

Dec. 2007

• Alberta Heritage Foundation for Medical Research Fellowship

($30,000/year)

1998-2001

• Edmonton Civic Employees Research Grant ($10,000 per year) – co-

applicant with Dr. A. Koshal

1998-2001

• Medical Research Council Summer Studentship ($5000) 1992

• Alberta Heritage Foundation Summer Studentship ($5000) 1991

Publications

Peer Reviewed Abstracts:

1. Manji RA, Samaha N, Koshal A, Guenther C. Comparison of continuous arterio-venous

hemodialysis with continuous veno-venous hemodiafiltration in the management of acute renal failure

in the cardiovascular surgery intensive care unit. Royal College of Physicians and Surgeons Meeting,

Montreal, Quebec. Sept. 1999.

2. Manji RA, Samaha N, Koshal A, Guenther C. The efficacy of continuous veno-venous

hemodiafiltration in the management of acute renal failure post-cardiopulmonary bypass in the


6

cardiovascular surgery intensive care unit. 4th International Congress on Continuous Renal

Replacement Therapy. San Diego, USA, Mar 1999.

3. Manji RA, Manji JS, Rajotte RV, Afrousian M, Yatscoff R, Koshal A. Specific -gal antibody

removal and human ABO blood group in human-porcine cardiac xenograft survival. Can J Cardiol

2000 Vol 16 Suppl F p.211.

4. Manji R, Manji JS, Koshal A, Afrouzian M, Rajotte RV. Specific -gal removal improves human-

porcine xenograft survival in and ex-vivo porcine working heart model. Clin and Invest Med 2000

Vol 23 (4) p.S6.

5. Manji RA, Manji JS Rajotte RV, Korbutt GS, Afrouzian M, Koshal A. The importance of -gal

antibody removal and human ABO blood group in human-porcine cardiac xenograft survival.

International Society of Cardiothoracic Surgeons – 10th World Congress. Vancouver Canada Aug.

2000.

6. Manji RA, Manji JS, Rajotte RV, Koshal A, Critical factors in survival of a pig-human xenograft. J

Mol Cell Cardiol 2001 Vol 33 (6) p.A7.

7. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Critical factors in survival of pig-human

xenograft. Can J Cardiol 2001 Vol 17 Suppl C p. 243C.

8. Manji RA, Manji JS, Koshal A, Korbutt GS, Rajotte RV. The ideal human ABO blood group and red

blood cells for porcine –to-human cardiac xenotransplantation. Xenotransplantation 2001 Vol 8 Suppl

1 p. 95

9. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Critical factors in survival of a pig-human

xenograft. Clin and Invest Med 2001 Vol 24 (4) p. 223.

10. Manji RA, Manji JS, Koshal A, Korbutt GS, Rajotte RV. The ideal human ABO blood groups for

porcine-human Xenotransplantation. Am J Trans 2001 Vol 1 Suppl 1 p. 457.

11. Manji RA, Manji JS, Koshal A, Korbutt GS, Rajotte RV. Are there ideal blood groups for porcine-

human xenotransplantation? Annual Scientific meeting of Canadian Society of Transplantation, Lake

Louise, Alberta, Mar 2001.

12. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Critical factors in survival of a pig-human

xenograft. 6th World Artificial Organ, Immunology, and Transplantation Society WAITS Ottawa,

Canada. August 2001.

13. Manji JS, Manji RA, Korbutt GS, Rajotte RV, Koshal A. Decreased apoptosis in alpha-gal antibody

depleted human plasma perfused porcine working cardiac xenografts. Can J Cardiol 2002 Vol 18

Suppl 8 p.192B.

14. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Human red blood cells in porcine-human

cardiac xenotransplantation. Can J Cardiol 2002 Vol 18 Suppl B p.209B

15. Manji JS, Manji RA, Korbutt GS, Rajotte RV, Koshal A. Human ABO blood group antibodies and

pig-to-human cardiac xenotransplantation. Can J Cardiol 2002 Vol 18 Suppl B p. 201B.

16. Manji RA, Nijjar N, Woolsey J, Rayner D, Rajotte R, Koshal A, Ross D. Is anti--gal antibody

involved in the failure of glutaraldehyde fixed bioprosthetic heart valves? Can J Cardiol 2004 Vol 20

Suppl D p. 165D


7

17. Manji RA, Nijjar NK, Zhu LF, Rayner DC, Korbutt GS, Churchill TA, Rajotte RV, Koshal A, Ross

DB. Glutaraldehyde-fixed xenograft bioprosthetic heart valve conduits calcify and fail from xenograft

rejection. Can J Cardiol 2005 Vol 21 SupplC p.215C.

18. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA, Rajotte RV, Koshal A, Ross

DB. Glutaraldehyde-fixed xenograft bioprosthetic heart valve conduits undergo T cell, macrophage

and antibody mediated rejection. Can J Cardiol 2005 Vol 21 Suppl C p.214C.

19. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Rajotte RV, Koshal A, Ross DB. Glutaraldehyde-fixed

heterograft (bioprosthetic) heart valve conduits fail from rejection mediated by T cells, and

macrophages. Exp & Clin Cardiol 2005 Vol 10(1) p. 63.

20. Manji RA, Nijjar N, Zhu LF, Rayner D, Rajotte RV, Koshal A, Ross DB. Glutaraldehyde-fixed

bioprosthetic heart valves fail due to xenograft rejection. 25th annual San Diego Cardiothoracic

Surgery Symposium. San Diego, California. February 2005.


bioprosthetic heart valves fail due to xenograft rejection. Annual Meeting of the Society of

Cardiothoracic Surgeons of Great Britain and Ireland. London, United Kingdom. March 2005


bioprosthetic heart valves fail due to xenograft rejection. 8th Annual NewEra Cardiac Care:

Innovation & Technology Meeting. Dana Point California. January 2005.

23. Rood PPM, Hara H, Tai H-C, Long C, Ezzelarab M, Lin Y-J, Busch J, Ball S, Ayares D, Wolf R,

Manji R, Bailey L, Cooper DKC. Development of anti-pig (anti-gal and anti-nongal) antibodies in

infant baboons and humans: implications for xenotransplantation. World Transplant Congress, Boston

Massachusetts, July 2006.

24. Kumar K, Durston M, Azordegan N, Bulman C, Moghadasian M, Manji R, Jassal DS, Arora RC.

Natural history of bioprosthetic valve failure. Annual American College of Surgeons Manitoba

Chapter meeting November 2007.

25. Manji RA, Leslie WD, MacWilliam L, Philipp R, Finlayson GS. Are the data any good? Can J

Cardiol 2008 Vol 24 Suppl E P. 258E.

26. Manji RA, Leslie WD, MacWilliam L, Philipp R, Finlayson GS. Does PCI or CABG work long

term? Can J. Cardiol 2008 Vol 24 Suppl E p. 309E.

27. Manji RA, Ross DB, Rajotte RV, Koshal A. Do young patients have antibody-mediated rejection of

bioprosthetic heart valves? Can J Cardiol 2008 Vol 24 Supple E p. 300E.

28. Kumar K, Zarychanski R, Bell D, Zivot J, Lee J Manji R, Menkis AH, Arora RC. The impact of the

Manitoba model of 24 hour in-house intensivists on a dedicated cardiac surgery ICU. Can J Cardiol

2008 Vol 24 Supple E p.113E.

29. Rivet M, Chartrand S, Henry G, Intensive care Cardiac Sciences Nurses, Arora RC, Bell D, Menkis

Ah, Zivot J, Manji RA. Bunk beds in the ICU – Can two cardiac surgery patients occupy one ICU

bed? Can J Cardiol 2008 Vol 24 Suppl E p. 116E.

30. Kumar K, Staniforth C, Durston M, Manji RA, Jassal DS, Arora RC. Can statin therapy alter the

natural history of bioprosthetic valves? Rationale, experimental design, and future implications. 11th

Annual NewEra Cardiac Care Conference. January 2008.


8

31. Manji RA, Ashan MW, CATSS Database Research Group, Kumar A. In septic shock patients with

low cardiac index, initial high or low pulmonary capillary wedge pressure is not useful to determine

ICU outcome. Crit Care Med 2009. Vol 37(12) p. A239.

32. Manji RA, Ashan MW, CATSS Database Group, Kumar A. Patients with septic shock and low

cardiac index have inadequate septic treatment and have worse outcomes. Crit Care Med 2009. Vol

37(12) p. A240.

33. Manji RA, Bell DD, Jacobsohn E, Singal RK, Arora RC, Zivot JB, Menkis AH. Consistent outcomes

despite sicker prolong stay ICU patients – A measure of improved quality of care? Crit Care Med

2009. Vol 37(12) p. A370.

34. Manji RA, Jacobsohn E, Grocott H, Zivot J, Menkis AH. Prolonged in-hospital wait times do not

affect outcomes for urgent coronary artery bypass surgery. American Heart Association, Orlando,

Florida, USA, Nov. 18, 2009. Abstract #4704.

35. Kumar K., Hiebert B, Zarychanski R, Bell DD, Singal RK, Manji RA, Zivot JB, Menkis AH, Arora

RC. Does the use of twenty-four hour, in-house intensivist staffing model in a dedicated cardiac

intensive care unit impact outcomes for prolonged stay (>48 hours) patients? Crit Care Med 2009.

Vol 37(12) p. A311.

36. Kumar K, Zieroth SR, Manji RA, Menkis AH, Freed DH. Influenza A (H1N1) causing biventricular

failure and multi-limb compartment syndrome. Crit Care Med 2009. Vol 37(12) p. A497.

37. Kumar KK, Azordegan N, Durston M, Li Y, Fischer G, Moghadasian M, Manji RA, Freed DH,

Jassal DS, Arora RC. Can statin therapy alter the natural history of bioprosthetic valves? – An in vivo

rodent model pilot study. Can J Cardiol 2009, Vol 25 Suppl B p. 85B.

38. Manji RA, Jacobsohn E, Grocott H, Zivot J, and Menkis AH. Prolonged in-hospital wait times do not

affect outcomes for urgent coronary artery bypass surgery. Can J Cardiol 2009, Vol 25 Suppl B p.

83B.

39. Manji RA, Warrian K, Pascoe E, Lee J, Arora RC, Freed DH, Singal RK, Menkis AH. Over the past

12 years, elderly patients undergoing coronary artery bypass grafting surgery have become sicker

needing more acute care post-op but still have similar mortality rates. Can J Cardiol 2009, Vol 25

Suppl B p.86B.

40. Manji RA, Bell DD, Saw C, Moltzan C, Nickerson P, Menkis AH, Zivot J, Jacobsohn E.

Management suggestions for cardiac surgery patients with a positive heparin induced

thrombocytopenia (HIT) ELISA. Can J Cardiol 2009 Vol 25 Suppl B p.86B.

41. Manji RA, Jacobsohn E, Bell DD, Singal RK, Zivot J, Menkis AH. Delirium and bed management in

the cardiac surgery ICU. Can J Cardiol 2009 Vol 25 Suppl B p.159B.

42. Manji RA, Witt J, Bell DD, Menkis AH, Zivot J, Jacobsohn E. Unfractionated heparin is the least

costly method of routine deep venous thrombosis prophylaxis after cardiac surgery in a model

considering the diagnosis, treatment and management of heparin induced thrombocytopenia. Can J

Cardiol 2009 Vol 25 Suppl B p.159B.

43. Kumar K, Zarychanski R, Bell D, Manji RA, Zivot J, Menkis AH, Arora RC. The impact of 24 hour

in-house intensivist coverage on a dedicated cardiac surgery ICU. Society of Thoracic Surgeons 45th

Annual meeting January 2009.


9

44. Kumar KK, Hiebert B, Zarychanski R, Grocott H, Singal RK, Manji RA, Menkis AH, Arora RC.

Twenty-four hour consultant hybrid ICU: addressing the needs of patients post-cardiac surgery. Can J

Cardiol 2010, Vol 26 Suppl SD Abstract #612

45. Avery LJ, Tam JW, Menkis AH, Shaikh N, Manji RA. What do non-rehab Cardiac Sciences Health

Professionals perceive of and know about cardiac rehab? Journal of Cardiopulmonary

Rehabilitation & Prevention, September/October 2010.

46. Manji RA, Grocott H, Leake J, Khan S, Black K, Manji JS, Menkis A, Strumpher J, Jacobsohn E.

Intermediate term outcomes in ICU patients with seizures following cardiac surgery. Crit Care

Med 2010. Vol 38(12). Abstract 611.

47. Manji RA, Grocott H, Saw C-L, Nickerson, P, Menkis A, Jacobsohn E. What is the usefulness of 4T

Test and Enzyme Linked Immunosorbent Assay in decision making in post cardiac surgical ICU

patients suspected of heparin induced thrombocytopenia? Crit Care Med 2010. Vol 38(12). Abstract

79.

48. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Which cardiac surgery ICU patients with a

positive heparin induced thrombocytopenia ELISA assay are at increased risk for thrombosis?

Canadian Critical Care Forum, November 2010, Toronto, Ontario.

49. Manji RA, Witt J, Menkis AH. A short course of low dose prophylactic steroids is cost-effective in

cardiac surgery ICU patients at medium to high risk for postoperative atrial fibrillation. Canadian

Critical Care Forum, November 2010, Toronto, Ontario.

50. Manji RA, Bell D, Freed DH. Elevated carboxyhemoglobin levels during extra-corporeal membrane

oxygenation for acute lung injury – A case report. Canadian Critical Care Forum, November 2010,

Toronto, Ontario.

51. Manji RA, Grocott HP, Leake JA, Manji JS, Menkis AH, Ariano R, Strumpher J, Jacobsohn E.

Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Circulation

Supplement Vol 122 Issue 21 November 23, 2010 – Abstract 18007

52. Manji RA, Grocott HP, Saw C, Nickerson P, Menkis AH, Jacobsohn E. Correlation of the 4T Test,

Enzyme Linked Immunosorbent Assay and the Serotonin Release Assay in post cardiac surgical ICU

patients suspected of heparin induced thrombocytopenia. American Society of Critical Care

Anesthesiologists meeting October 2010, San Diego, California.

53. Manji RA, Grocott HP, Saw C, Nickerson P, Menkis AH, Jacobsohn E. Thrombosis risk in cardiac

surgery ICU patients suspected of having heparin induced thrombocytopenia. American Society of

Critical Care Anesthesiologists meeting October 2010, San Diego, California.

54. Manji RA, Grocott HP, Leake JA, Manji JS, Menkis AH, Jacobsohn E. Risk factors for seizures in

cardiac surgery ICU Patients. American Society of Critical Care Anesthesiologists meeting October

2010, San Diego, California.

55. Manji RA. Ventricular Arrhythmia: Perioperative management. 12th International Congress on

Cardiothoracic and Vascular Anesthesia 2010. Abstract 35. Beijing, China Sept 23, 2010.

56. Manji RA, Bell DD, Loong-Saw C, Nickerson P, Moltzan C, Menkis AH, Jacobsohn E. Treating

cardiac surgery patients for heparin-induced thrombocytopenia based on easily available ELISA

results. Anesthesia and Analgesia 2010. Vol 110 (3) Abstract 71.


10

57. Manji RA, Warkentin TE, Grocott HP, Menkis AH, Jacobsohn E. Pre-operative, intra-operative and

post-operative factors associated with heparin induced thrombocytopenia post cardiac surgery.

Canadian Journal of Cardiology Supplement Vol 27 (5S) September/October 2011 Page S103.

Abstract 111.

58. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Risk factors associated with recurrent seizures

following cardiac surgery. Canadian Journal of Cardiology Supplement Vol 27 (5S)

September/October 2011 Page S195. Abstract 373.

59. Manji RA, Chartrand S, Arora RC, Rivet M, Jacobsohn E, Bell DD, Menkis AH. Which cardiac

surgery patients may be suitable for transfer from ICU the same day as surgery? Canadian Journal of

Cardiology Supplement Vol 27 (5S) September/October 2011 Page S197. Abstract 377.

60. Manji RA, Witt J, Menkis AH. Is it cost-effective to give a short course of low dose prophylactic

steroids to cardiac surgery ICU patients at medium to high risk for postoperative atrial fibrillation.

Canadian Journal of Cardiology Supplement Vol 27 (5S) September/October 2011 Page S288.

Abstract 620.

61. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Recurrent seizures following cardiac surgery - risk

factors and outcomes. Circulation Supplement November 22, 2011, 124 (21):A13710

62. Manji RA, Warkentin TE, Grocott HP, Menkis AH, Jacobsohn E. What is the utility of two different

ELISAs and the 4T's Score in determining the probability of heparin-induced thrombocytopenia

following cardiac surgery? Circulation Supplement November 22, 2011, 124 (21):A13172

63. Villafranca AJ, Arenson B, Grocott H, Manji RA, Jacobsohn E. Is there a difference between cardiac

surgical practice between Canada and the US? Can J Anesth (2012) 59:S123 – Abstract 1343388

64. Manji RA, Arora RC, Bell DD, Menkis AH, Jacobsohn E. Can cardiac surgery patients transfer from

ICU the same day as surgery? Can J Anesth (2012) 59:S108 – Abstract 1341611

65. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Which cardiac surgery ICU patients with a

positive HIT ELISA are at increased risk for thrombosis? Can J Anesth (2012) 59:S113 – Abstract

1341903

66. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Outcomes in ICU patients with seizures post

cardiac surgery. Can J Anesth (2012) 59:S111 – Abstract 1341774

67. Manji RA, Witt J, Jung Y, Northcott R, Jacobsohn E, Menkis AH. Determining the most cost-

effective method to prevent rheumatic heart disease in a developing world country. Accepted for

poster presentation at the American Heart Association Meeting November 4, 2012, Los Angeles,

California, USA

68. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Seizures post cardiac surgery: In-hospital

mortality and intermediate term outcomes. Canadian Journal of Cardiology Supplement Vol 28 (5S)


69. Manji RA, Grocott HP, Menkis AH, Jacobsohn E. Aortic surgery patients with a positive HIT

ELISA are at increased risk of thrombosis. Canadian Journal of Cardiology Supplement Vol 28 (5S)


70. Manji RA, Witt J, Menkis AH. Is it more cost-effective to use steroids or colchicine in patients at

moderate to high risk for atrial fibrillation to prevent post-cardiac surgery atrial fibrillation? Canadian

Journal of Cardiology Supplement Vol 28 (5S) September/October 2012 Page S384. Abstract 742.

71. Manji RA Witt J, mankis AH. What is the most cost effective method to prevent atrial fibrillation in

patients at medium to high risk for post cardiac surgery atrial fibrillation? Society of Critical Care

Anesthesiologists Annual Meeting, Oct. 2013 San Francisco, California, USA.


11

72. Kumar K, Azordegan N, Durston M, Li Y, Fischer G, Moghadasian M, Manji RA, Freed DH, Jassal

RC, Arora RC. HMG-COA reductase inhibitors do no attenuate the inflammatory response associated

with glutaraldehyde-fixed bioprosthetic heart valve conduits. Can J Cardiol. 2013 Oct; 29(10):S261.

73. Manji RA, Northcott R, Menkis AH. Cardiovascular risk profile in a developing world country –

Rural versus urban differences. Can J Cardiol. 2013 Oct; 29(10):S278.

74. Manji RA, Witt J, Jung Y, Northcott R, Menkis AH. Whit is the most cost-effective method to

prevent rheumatic heart disease in a developing world country? Can J Cardiol. 2013 Oct;

29(10):S324.

75. Manji RA, Northcott R, Menkis AH. Cardiovascular disease risk perception in a developing world

country – based on location of residence and gender. Can J Cardiol. 2013 Oct; 29(10):S324-S325.

76. Nepomuceno R, White CW, Muthiah K, Bueddefield D, Hiebert B, Arora RC, Manji RA, Freed DH,

Moffatt D. Gastrointestinal hemorrhage in adults requiring extracorporeal membrane oxygenation:

Incidence, clinical predictors, and impact on outcomes. Can J Cardiol. 2013; 29(10):S373-S374.

77. Villafranca A, Manji RA, Thomson IA, Arenson B, Lucht J, Jacobsohn E. Differentiation of Heparin

and Non-Heparin Induced Thrombocytopenia Through Early Platelet Measures. Can J Cardiol. 2013;

29(10):S226-S227.

78. Manji RA, Villafrance A, Grocott H, Menkis AH, JacobsohnE. Diagnosing heparin induced

thrombocytopenia post cardiac surgery. American Heart Association Meeting November 2013,

Dallas, Texas USA

79. Manji RA, Menkis AH, Cooper DKC. Xenograft rejection of bioprosthetic heart valves.

Xenotransplantation 2013; 20(5):361

80. Manji RA, Rayner D. Do bioprosthetic heart valves undergo xenograft rejection in patients?

Xenotransplantation 2013; 20(5):373.

81. Manji RA, Rayner D. Anti-alpha-Gal antigen/antibody may not be important in the failure of

bioprosthetic heart valves. Xenotransplantation 2013:20(5):336.

82. Manji RA, Villafranca A, Grocott H, Menkis AH, Jacobsohn E. Testing for Heparin Induced

Thrombocytopenia After Cardiac Surgery. Electronic (moderated) Poster Presentation at Canadian

Anesthesiologist Society Meeting June 13-16, 2014, St. John’s, Newfoundland.

83. Manji RA, Hiebert BM, Arora RC, Moon MC, Freed DH, Menkis AH. Readmission rates and

diagnoses for prolonged intensive care unit stay survivors following cardiac surgery. Can J Cardiol.

2014; 30(10S):S231.

84. Manji RA, Hiebert BM, Arora RC, Moon MC, Freed DH, Menkis AH. Social Assistance

requirements and mental health issues of patients needing prolonged intensive care unit stay

following cardiac surgery. Can J Cardiol. 2014;30(10S):S235.

85. Bednarczyk JM, Ducas RA, White CW, Golian M, Nepomuceno R, Bueddefeld D, Hiebert B, Manji

RA, Singal RK, Hussain F, Freed DH. Extracorporeal membrane oxygenation facilitates survival in

refractory in-hospital cardiac arrest and cardiogenic shock. Can J Cardiol. 2014; 30(10S):S242.

86. Manji RA, Hiebert B, Arora RC, Moon MC, Freed DH, Menkis AH. Characteristics, long-term

survival and predictors of mortality of patients needing prolonged intensive unit care stay post cardiac

surgery. Podium presentation at University of Manitoba Department of Surgery Research Day –

January 19, 2015 – Winnipeg, Manitoba. 87. Manji RA, Hiebert B, Arora RC, Moon MC, Freed DH, Menkis AH. Long Term Survival and

Predictors of Mortality in Patients Needing Prolonged Intensive Unit Care Stay Post Cardiac Surgery.

Podium presentation at the Society of Thoracic Surgery Meeting (Abstract 1542) – San Diego,

California – January 26, 2015.


12

Other Abstracts:

1. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Development of an ex-vivo porcine

working heart model to test various immunoadsorbants for porcine to human xenotransplantation.

General Surgery Resident Research Day, University of Alberta, Edmonton Alberta. Apr 1999.

2. Manji RA, Manji JS, Rajotte RV, Koshal A. Specific -gal antibody removal and human ABO

blood group in human=porcine cardiac xenograft survival. 4th Annual Cardiac Sciences Research

Day, University of Alberta, Edmonton, Alberta, June 2000.

3. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Testing the efficacy of specific anti--gal

antibody depletion at prolonging survival of an ex-vivo porcine working heart in porcine-human

cardiac xenotransplantation. General Surgery Resident Research Day. University of Alberta,

Edmonton, Alberta. Apr. 2000.

4. Manji RA, Manji JS, Rajotte RV, Koshal A. Critical factors in porcine-human Xenotransplantation.

Department of Surgery Resident Research Day, University of Alberta, Edmonton, Alberta, May 2001.

5. Manji RA, Manji JS, Rajotte RV, and Koshal A. Critical factors in survival of a pig-human

xenograft. 5th annual Cardiac Sciences Research Day. University of Alberta, Edmonton, Canada.

June 2001.

6. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Human red blood cells in pig-human

cardiac xenotransplantation. 6th Annual Cardiac Sciences Research Day University of Alberta,

Edmonton, Alberta, Canada. June 2002.

7. Manji JS, Manji RA, Rajotte RV, Korbutt GS, Koshal A. Decreased apoptosis in -gal antibody

depleted human plasma perfused porcine working cardiac xenografts. 6th Annual Cardiac Sciences

Research Day, University of Alberta, Edmonton, Canada. June 2002.

8. Manji JS, Manji RA, Rajotte RV, Korbutt GS, Koshal A. Human ABO blood group antibodies and

pig-to-human cardiac xenotransplantation. 6th Annual Cardiac Sciences Research Day. University of

Alberta, Edmonton, Canada June 2002.

9. Manji RA, Manji JS, Rajotte RV, Korbutt GS, Koshal A. Human red blood cells in porcine-human

cardiac xenotransplantation. Department of Surgery Resident Research Day, University of Alberta,

Edmonton, Canada May 2002.

10. Manji RA, Rayner D, Woolsey J, Nijjar N, Rajotte R, Koshal A, Ross D. Are glutaraldehyde-fixed

bioprosthetic heart valves truly inert? Cardiac Sciences Research Day, Edmonton, Canada June 2004.

11. Manji RA, Nijjar N, Woolsey J, Rayner D, Rajotte R, Koshal A, Ross D. Is anti--gal antibody

involved in the failure of glutaraldehyde fixed bioprosthetic heart valves? Cardiac Sciences Research

Day Edmonton, Alberta June 2004.

12. Kumar K, Durston M, Azordegan N, Bulman C, Moghadasian M, Manji RA, Jassal DS, Arora RC.

Bioprosthetic valve implantation in a rodent model: analysis of the immunological response. Institute

of Cardiac Sciences Research Day, University of Manitoba, Winnipeg, Manitoba. November 2008.

13. Kumar K, Azordegan N, Durston M, Li Y, Fischer G, Moghadasian M, Manji RA, Freed DH, Jassal

DS, Arora RC. Statins compared to steroids on bioprosthetic heart valve inflammation – An In- vivo


13

rodent model study. Institute of Cardiovascular Sciences Research Day, November 2010, Winnipeg,

Manitoba.

Manuscripts and Book Chapters:

1. Bertie JE, Zhang S, and Manji RA, Infrared intensities of liquids X: Accuracy of current methods of

obtaining optical constants from multiple attenuated total reflection measurements using the circle

cell. Applied Spectroscopy 1992; 46:1660.

2. Manji RA and Warnock GL. Left paraduodenal hernia. An unusual case of small bowel obstruction.

Can J Surg 2001; 44(6):455.

3. Manji RA, Manji JS, Koshal A, Korbutt GS, and Rajotte RV. Human ABO blood group is important

in survival and function of porcine working hearts. Am J Trans 2003; 3:286-93.

4. Manji RA, Rajotte RV, Koshal A. human O red blood cells and pig-to-human xenotransplantation.

Xenotransplantation 2004:11:107.

5. Manji RA, Manji JS, Rajotte RV, Koshal A. Xenotransplantation: An Overview. In Pathophysiology

of Cardiovascular Disease. Edited by N.S. Dhalla, H. Rupp, A. Angel and GN Pierce. Kluwer

Academic publishers, Boston 2004:555.

6. Manji JS, Rajotte RV, Koshal A, Manji RA. Increased apoptosis in porcine cardiac xenografts

perfused with human ABO plasma containing the anti-B antibody. Xenotransplantation 2004; 11:378-

9.

7. Manji JS, Rajotte RV, Koshal A, Manji RA, Human anti-A and anti-B antibodies interact with anti-

-gal antibody affecting xenograft survival. Xenotransplantation 2004; 11:376-7.

8. Manji RA Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA. Rajotte RV, Koshal A, Ross

DB. Glutaraldehyde-fixed Bioprosthetic heart valve conduits calcify and fall from xenograft rejection.

Circulation 2006; 114:318-27.

9. Rood PP, Tai H-Chara H, long C, Ezzelarab M, Lin Y-J, van der Windt DJ, Busch J, Ball S, Ayares

D, Ijzermans JNM, Wolf RF, Manji RA, Bailey L, Cooper DKC. Late onset of development of anti-

nongal antibodies in infant humans and baboons: Implications for xenotransplantation in infants.

Transplant International 2007; 20(12):1050.

10. Tam JW, Manji RAS, Shaikh N, Morris A. Diagnostic approach to endocarditis. In Endocarditis:

Diagnosis and Management. Eds.: Chan KL, Embil J, Springe-Verlag, London. 2008; p.63.

11. Schaffer SA, Manji RA, Kirkpatrick I, Fang T, Arora RC, Zieroth S, Jassal DS. Negative pressure

pulmonary edema in the coronary care unit. Can J Cardiol 2008; Sep. 29(9): e58

12. Manji RA, Wood KE, Kumar A. The history and evolution of circulatory shock. Crit Care Clin 2009

Jan. 25(1):1-29, vii.

13. Kumar K, Zarychanski R, Bell DD, Manji RA, Zivot J, Menkis AH, Arora RC. The Impact of 24

hour in-house intensivist coverage on a dedicated cardiac surgery ICU. Annals of Thoracic Surgery

2009 Oct 88 (4): 1153 - 61.

14. Freed D, Henzler D, White C, Fowler R, Zarychanski R, Hutchison JS, Arora R, Manji R, Legare J-

F, Drews T, Veroukis S, Kesselman M, Guerguerian A-M, Kumar A. Extracorporeal lung support for


14

patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in

Canada. Can J Anaesth. 2010 Mar;57(3):240-7.

15. Manji RA, Kumar A. Determining relevant cortisol concentrations in critically ill patients. Critical

Care 2010; 14:113.

16. Paunovic B, Manji RA, Arora R, Strumpher J, Sigal R, Zivot J, Jacobsohn E. Chapter 17: Sepsis and

Vasodilatory Shock in the Cardiac Surgical Patient. In: Sladen RN, ed. Postoperative Cardiac Care.

A Society of Cardiovascular Anesthesiologists Monograph. Baltimore: Lippincott Williams &

Wilkins, 2011:335.

17. Manji RA, Menkis AH, Cooper DK. Cardiac xenotransplantation technology provides materials for

improved bioprosthetic heart valves. J Thorac Cardiovasc Surg 2011 Jul;142(1):238-9.

18. Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, Jacobsohn E. Seizures following

cardiac surgery: the impact of tranexamic acid and other risk factors. Canadian Journal of Anesthesia:

Volume 59, Issue 1 (2012), Page 6-13

19. Manji RA, Menkis AH, Ekser B, Cooper DKC. The future of bioprosthetic heart valves. Indian J

Med Res. 2012 Feb; 135(2):150-51

20. Manji RA, Menkis AH, Ekser B, Cooper DKC. Porcine bioprosthetic heart valves: the next

generation. Am Heart J. 2012 Aug; 164(2):177-85.

21. Manji RA, Jacobsohn E, Grocott HP, Menkis AH. Longer in-hospital wait times do not result in

worse outcomes for patients requiring urgent coronary artery bypass graft surgery. Hosp Prac (1995)

2013; 41(3):15-22.

22. Manji RA, Witt J, Tappia PS, Jung Y, Menkis AH, Ramjiawan B. Cost effectiveness analysis of

rheumatic heart disease prevention strategies. Expert Rev. Pharmecoecon Outcomes Res.

2013;13(6):715-24.

23. Manji RA, Menkis AH, Ekser B, Cooper DKC. Bioprosthetic heart valves of the future.

Xenotransplantation 2014; 21(1):1-10.

24. Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, Wells PS, Crowther MA. Design of

the rivaroxaban for heparin-induced thrombocytopenia study J .Thromb Thrombolysis

2014;38(4):485-92.

25. Manji RA, Cardiac Surgery in the Developing World. Perfusionist 2014; 24(1): p.31

26. Kumar K, Singal R, Manji RA, Zarychanski R, Bell DD, Freed DH, Arora RC; Cardiovascular

Health Research in Manitoba Investigator Group. The benefits of 24/7 in-house intensivist coverage

for the prolonged stay cardiac surgery patient. J Thorac Cardiovasc Surg. 2014 Jul;148(1):290-297.

27. Bednarycyk JM, White CW, Ducas RA, Golian M, Nepomucena R, Hiebert B, Bueddefeld D,

Manji RA, Singal RK, Hussain F, Freed DH. Resuscitative extracorporeal membrane oxygenation

for in hospital cardiac arrest: A Canadian observational experience. Resusciation

2014;85(12):1713-9.

28. Lee W, Hara H, Cooper DK, Manji RA. Expression of NeuGc on pig heart valves.

Xenotransplantation. 2015 Mar 6. doi: 10.1111/xen.12162. [Epub ahead of print]

29. Manji RA, Grocott HP, Manji JS, Menkis AH, Jacobsohn E. Recurrent seizures following cardiac

surgery: risk factors and outcomes in a historical cohort study. Journal of Cardiothoracic and

Vascular Anesthesia (in press - Manuscript Number: YJCAN_3243)

30. Manji RA, Arora RC, Singal RK, Hiebert B, Moon MC, Freed DH, Menkis AH. Long Term

Outcome and Predictors of Non-Institutionalized Survival after Prolonged ICU Stay Post Cardiac


15

Surgery (provisionally accepted for publication in the Annals of Thoracic Surgery pending

revisions– manuscript number ATS/2015/484782).

31. Kumar K, Azordegan N, Durston M, Li Y, Fischer G, Moghadasian M, Manji RA, Freed DH,

Jassal DS, Arora RC. HMG-CoA reductase inhibitors do not attenuate in the inflammatory response

associated with glutaraldehyde fixed bioprosthetic heart valve conduits. (submitted to Circulation)

Invited Presentations

• Xenograft Rejection of Bioprosthetic Heart Valves – Workshop:

Strategies for Overcoming Xenograft Loss – 12th Congress for the

International Xenotransplantation Association – Osaka, Japan

Nov. 13, 2013

• CJOB 680 Radio – World Heart Day – St. Boniface Hospital Global

Heart Initiative

Sept. 29, 2013

• Outcomes of Patients with Prolonged Length of Stay in ICU after

Cardiac Surgery – Combined Cardiac Anesthesia and Cardiac

Surgery Grand Rounds – St. Boniface Hospital – Winnipeg,

Manitoba

Feb. 25, 2015

• Outcomes of Patients with Prolonged Length of Stay in ICU After

Cardiac Surgery – Research in Progress – University of Manitoba

Critical Care Medicine – Winnipeg, Manitoba

Nov. 13, 2014

• Cardiac Surgery in the Developing World – An Update – CSCS

Annual General Meeting at CCS – Vancouver, British Columbia

Oct. 26, 2014

• Cardiac Surgery in the Developing World: Opportunities for the

Cardiac Anesthesiologist – Canadian Anesthesiologist Society

Annual Meeting– St. John’s, Newfoundland

Jun 14, 2014

• Opportunities: Cardiac Surgery in the Developing World – Canadian

Society of Cardiac Surgeons Spring Meeting – Quebec City,

Quebec

Jun 6, 2014

• Colchicine is the Most Cost Effective Method to Prevent Post Cardiac

Surgery Atrial Fibrillation – Critical Care Medicine Research In

Progress Rounds, University of Manitoba, Winnipeg, Manitoba

Dec. 12, 2013

• Opportunities: Cardiac Surgery in the Developing World – Winnipeg

Cardiac Anesthesia, St. Boniface Hospital, Winnipeg, Manitoba

Dec. 3, 2013

• Opportunities: Cardiac Surgery in the Developing World – Canadian

Society of Clinical Perfusion– Montreal, Quebec

Oct 26, 2013

• Opportunities: Cardiac Surgery in the Developing World – Vascular

2013 Conference – Montreal, Quebec

Oct 27, 2013

• Heparin Induced Thrombocytopenia- Critical Care Rounds – Royal

Jubilee Hospital, Victoria, British Columbia

Aug. 30, 2012


16

• Heparin Induced Thrombocytopenia – Cardiology Grand Rounds –

Winnipeg, Manitoba

Jun. 4, 2012

• Seizures Post Cardiac Surgery – Critical Care Medicine Research In

Progress Rounds, University of Manitoba, Winnipeg, Manitoba

Apr. 5, 2012

• Opportunities in the Developing World – Cardiac Sciences Program,

Winnipeg, Manitoba

Mar. 19, 2012

• Heparin Induced Thrombocytopenia – Critical Care Nurses–

University of Manitoba, Winnipeg, Manitoba

Nov. 22, 2011

• Seizures Post Cardiac Surgery – Critical Care Database Meeting –

Winnipeg, Manitoba

Oct. 5, 2011

• Heparin Induced Thrombocytopenia – Department of Anesthesia

Grand Rounds – University of Manitoba, Winnipeg, Manitoba

Sept. 7, 2011

• Heparin Induced Thrombocytopenia – Department of Surgery

Research Rounds– University of Manitoba, Winnipeg, Manitoba

Jan. 14, 2011

• Heparin Induced Thrombocytopenia – Cardiac Surgery Grand

Rounds– University of Manitoba, Winnipeg, Manitoba

Jan. 12, 2011

• Ventricular Arrhythmias: Perioperative Management. 12th

International Congress of Cardiothoracic and Vascular Anesthesia,

Beijing, China

Sept. 23, 2010

• Diabetes: The Basics – Ismaili Muslims Congregation – Winnipeg,

Manitoba

Jun. 3, 2010

• Sharing Best Practices in Cardiac Rehabilitation – “Factors affecting

referrals to cardiac rehabilitation: WRHA Cardiac Sciences Staff

Perceptions”. Canadian Cardiac Rehabilitation Conference,

Edmonton, Alberta

Oct. 25, 2009

• “Heart Valves and Rejection of Bioprosthetic valves” – CJOB Health

Report Broadcast with Stuart Murray, Winnipeg, Manitoba

March 22, 2009

• “Patient Safety and Quality Improvement” – Grand Rounds Critical

Care Medicine, University of Manitoba, Winnipeg, Manitoba

Feb. 18, 2009

• “Patient Safety and Quality Improvement” – Presentation to ICU

Nurses, University of Manitoba, Winnipeg, Manitoba

Feb. 17, 2009

• Cardiovascular Disease – Ismaili Muslims Congregation – Winnipeg,

Manitoba

Feb. 13, 2009

• Cancer Screening - Ismaili Muslims Congregation – Winnipeg,

Manitoba

Jun. 19, 2008

• “Do Bioprosthetic Valves Reject?” – Cardiac Surgery Grand Rounds,

University of Calgary, Calgary, Alberta

March 31, 2006


17

TEACHING

Teaching Experience

• Lecturer – Critical Care Medicine Clinical Assistant Program –

Heparin Induced Thrombocytopenia

Mar 14, 2013

• Lecturer – Critical Care medicine Clinical Assistant program –

Weaning from Mechanical Ventilation and Neuromuscular

Weakness

Mar 14, 2013

• Lecturer – Business Management Issues for ICU - Critical Care

Residents/Fellows, University of Manitoba

October 2011 - present

• Lecturer (with Dr. Julia Witt – Health Economics) - Economic May 2012 - present

• “Databases, Report Cards, Continuous Quality Improvement

Initiatives and Cardiovascular Care in Canada.” 6th Annual

Cardiovascular Trainee Luncheon Co-Chair, Canadian

Cardiovascular Congress, Montreal, Quebec

Oct. 23, 2005

• “Surgical Options for Heart Failure: Expanding Indications for

Cardiac Transplantation and the Future of Xenotransplantation.”

Plenary Session – Postgraduate Day, Canadian Cardiovascular

Congress, Edmonton, Alberta

Oct. 25, 2002

• Open Forum on Xenotransplantation – Expert Panelist for informing

public on the scientific aspects of xenotransplantation

November 3, 2001

• “-gal Antibody Depletion and the Ideal Human Blood Group for

Porcine-Human Cardiac Xenotransplantation.” Alberta Chapter of

the American College of Surgeons, Canmore, Alberta

February 16-19, 2001

• “Porcine-Human Xenotransplantation and Public Health”, Public

Health Sciences Graduate Student Association Public Health Grand

Rounds, University of Alberta, Edmonton, Alberta

Mar. 28, 2001

• “Specific a-Gal Antibody Removal and Human ABO Blood Group in

Human-Porcine Cardiac Xenograft Survival.” Canadian Association

of General Surgeons Resident Research Conference, Parry Sound,

Ontario

June 15-17, 2000

• “Development of and Ex-vivo Porcine Working Heart Model to Test

Various Immunoadsorbants for Porcine to Human

Xenotransplantation, Alberta Research Council, Edmonton, Alberta

Dec. 1999


18

Evaluation of Healthcare Studies – Critical Care Residents/Fellows,


• Medical Simulation for Critical Care Residents/ Fellows Nov 2011 – present

• Lecturer – Wean From Ventilation and Neuromuscular Disease in the

ICU – Physician Assistant Lecture Series

Feb 2011 - present

• Lecturer – Heparin Induced Thrombocytopenia – Critical Care

Residents/ Fellows, University of Manitoba

2010 - present

• Lecturer - “Cardiac Surgery for the Medical Student” – Med 3/4

Surgery Students, University of Manitoba

2010 - present

• Lecturer - Abstract Writing– Cardiac Sciences and Critical Care

Residents/Fellows, University of Manitoba

Feb. 2009 - Present

• Lecturer – Patient Safety and Quality Improvement – Cardiac

Sciences and Critical care Residents/Fellows, University of Alberta

Feb. 2009 - Present

• Lecturer and Tutorial Instructor – CV042 “Shock” – Med 1 Students,


Oct. 2007 - Present

• Lecturer and Tutorial Instructor – CV042 – “Valvular Heart Disease

Part 2” – Med 1 Students, University of Manitoba

Oct. 2007 - Present

• Tutorial Instructor – Hemodynamics – Med 1 Students, University of

Manitoba

Oct. 2007 - Present

• Lecturer – ICU Nursing Course – “Altered Lab Values” – University

of Manitoba

Oct. 2007 - Present

• Lecturer – ICU Fellows Lecture Series – “Applying Business

Principles to Health Care” – University of Manitoba

Oct. 2007 - Present

• Resident and Medical Student Teaching and Evaluations (ICU

procedures, resuscitation)

July 2005 - Present

• Medical Student Teaching (Surgery Student Interns, Year II Medical

Students) – ward teaching, suture skills, surgery OSCE exams

1996 - 2005

• Advanced Trauma Life Support, Basic Trauma Life Support, and

Advanced Cardiac Life Support Instructor

1998 - 2005

Supervisory Experience

• Summer Student:

o Young Jung – Department of Economics and Pre-med –

CEA for Delirium

Summer 2013

• Summer Students

o Derek Bueddefeld – medical student – Primary supervisor

Summer 2012


19

o Alec Thompson – graduate student – Co-supervisor

o Alex Villafranca – graduate student

o Ben Arenson – summer student

• Summer Students (during my residency)

o Mr. Akil Gulamhusein

o Ms. Nimrit Nijjar

o Ms. Jennifer Woolsey

2001-2004

Administrative/Service

Committees

• Medical Advisory Committee – St. Boniface Hospital, Winnipeg,

Manitoba

2014-present

• The Committee on Management and Governance of Overhead –

University of Manitoba, Winnipeg, Manitoba

2014-present

• ICU Academic Funding Committee – University of Manitoba,

Winnipeg, Manitoba

2014-present

• GFT (geographic full-time) Liason Committee – University of

Manitoba, Winnipeg, Manitoba

2013-present

• Surgery Representative on Canadian Critical Care Society Board of

Directors

2013-present

• Chairman of the Board of Directors – Canadian Humanitarian –

Winnipeg Chapter

Nov 2012-present

• Deep Venous Thrombosis Protocol Policy Committee – Cardiac

Surgery

Jan 2012 - present

• Ventilator Associated Pneumonia Quality Control Committee

Member

Sept 2011 - present

• APPROACH Executive Leader 2010-present

• Member of the Board of Directors of the Canadian Intensive Care

Foundation

Oct. 2009-present

• Treasurer – Canadian Intensive Care Foundation Oct. 2010 - present

• Member of Standards Committee for Cardiac Sciences Program –

Winnipeg Regional Health Authority

May 2009 - Present

• Bleed Audit Committee - Cardiac Surgery 2010 - present

• Residency training Committee – Critical Care Medicine July 2005 - 2007

• Member of Transition Working Group for Trainees for Canadian Mar. 2005 - 2006


20

Cardiovascular Society

• Surgery Resident representative on Surgical Research Committee,


1999 - 2001

• Medical Student Association’s representative to the General Faculties

Council – University of Alberta

1993 - 1994

Other Administrative/Service

• Examiner for National Assessment Collaboration – Medical Council

of Canada for International Medical Graduates

• Chair Canadian Cardiovascular Congress oral session: Information

Technology in Cardiac Rehabilitation – The Way of the Future

2012 - present

Oct. 2014

• Invited reviewer for “Journal of Medical Economics” Nov. 2014

• Invited reviewer for Donalda Huggins Scholarship Award in

Anesthesia – Dept. of Anesthesia – University of Manitoba,

Winnipeg, Manitoba

2014-present

• Reviewer for journal “Clinical Medicine Insights: Cardiology” June 2014

• Liaison between Canadian Society of Cardiac Surgeons and Cardiac

Centre for Ethiopia for establishment of cardiac surgery program in

Addis Ababa, Ethiopia

2013 - present

• CJOB 680 Radio – World Heart Day – St. Boniface Hospital Global

Heart Initiative

Sept. 29, 2013

• International Medical Graduate OSCE Examiner Sept. 18, 2013 - present

• Invited Reviewer for “Xenotransplantation” Sept. 2013 - present

• Editorial Board of “Journal of Transplantation” Aug 2013 - present

• Invited Reviewer for Journal Biological Medical Research May 2013

• India Canada Culture and Heritage Association Inc. Symposium and

Mentorship Program for Career Development – Medicine as a

Career Choice – Winnipeg, Manitoba

May 4, 2013

• Sanofi BioGENEius Challenge Grade 9-12 Science fair judge - St.

Boniface Research Centre

Mar 21, 2013

• Trip to Ethiopia with Canadian Humanitarian – Echo/Spirometry Feb 2013

• Reviewer for Seizure: European Journal of Epilepsy Jan 2013

• Reviewer for National Research Foundation of South Africa 2012, 2013

• Abstract reviewer for Canadian Cardiovascular Society Annual

Meeting

May 2012-present


21

• Editorial Board – CV Network June 2011- present

• Abstract reviewer for Canadian Cardiovascular Society Annual

Meeting

May 2011

• CIHR High School Student Science Fair Judge – St. Boniface

Research Center

April 2011 and April 2012

• Poster moderator – Society of Critical Care Medicine Annual Meeting January 2011

• External reviewer for Journal – “Circulation” January 2011

• Abstract reviewer – Society of Critical Care Medicine Sept. 2010

• External reviewer “Circulation Surg Suppl” Dec. 2009

• Co-Chair Oral Session – Applied Basic Science II – Canadian

Cardiovascular Congress, Edmonton, Alberta

Oct. 2009

• Grant reviewer for Canadian Critical Care Trials Group/Canadian

Intensive Care Foundation

Oct. 2009-present

• Abstract Reviewer for Canadian Cardiovascular Congress National

Meeting for October 2009

May 2009

• Sponsor for Stuart Clark Entrepreneurial Business Competition –

Asper School of Business – University of Manitoba

April 2008

• Judge at Cardiac Sciences Research Day – University of Manitoba May 2008

• Reviewer for “Journal of American College of Cardiology” Feb. 2008

• Reviewer for “Journal of Cellular and Molecular Medicine” Oct. 2007

• Reviewer for journal “Xenotransplantation” May 2007

• Abstract Reviewer for Canadian Cardiovascular Congress October

2007

May 2007

• Abstract reviewer for Canadian Cardiovascular Congress Oct. 2006 May 2006

• External Reviewer for journal “Circulation” Feb. 2005 - present

• External Reviewer for journal “Nephron” Dec. 2004

• External Reviewer for Candidate for promotion to Research Associate

Professor of Surgery without Tenure, University of Pittsburgh

Sept. 2004

Affiliations/Memberships

• CANCARE October 2014 - present

• Society of Thoracic Surgeons Jan 2011 - Present

• Canadian Critical Care Trials Group Member July 2009 - Present

• Cardiothoracic Surgery Critical Care Association Oct. 2007 - Present


22

• Society of Critical Care Medicine 2005 - Present

• Alpha Omega Alpha Honour Medical Society 1994 – Present

• Canadian Medical Association, Alberta Medical Association 1991 - Present

• Immunology Network Group, University of Alberta 1998 – 2005

• Canadian Association of General Surgeons 1997 - 2001

rizwan a. manji md phd frcsc mba - umanitoba.ca · rizwan a. manji md phd frcsc mba 2 • cae...

Documents